Bronchial asthma: new prospects in therapy
The article reviews original and literature data on the use of monoclonal antibodies (MAB) for treatment of patients with severe bronchial asthma (BA), methods of MAB obtaining. Biomolecule targets in BA are some immunoglobulins, CD4 lymphosytes and TNFalpha. Successful use of monoclonal anti-IgE an...
Main Author: | A G Chuchalin |
---|---|
Format: | Article |
Language: | Russian |
Published: |
"Consilium Medicum" Publishing house
2012-03-01
|
Series: | Терапевтический архив |
Subjects: | |
Online Access: | https://ter-arkhiv.ru/0040-3660/article/view/30982 |
Similar Items
-
Current trends in the treatment of bronchial asthma
by: Oksana M. Kurbacheva, et al.
Published: (2019-03-01) -
Severe bronchial asthma patient care organization in various regions of the Russian Federation. From endotypes and phenotypes of bronchial asthma to personalized choice of therapy
by: S. N. Avdeev, et al.
Published: (2020-02-01) -
Polish Society of Allergology statement on the diagnosis and treatment of severe, difficult-to-control bronchial asthma
by: Maciej Kupczyk, et al.
Published: (2019-05-01) -
The Long-Term Omalizumab Therapy in Children with Severe Persistent Uncontrolled Asthma: Evaluation of the Outcomes According to the Data of the Hospital Patient Registry
by: Elena A. Vishneva, et al.
Published: (2018-05-01) -
Bronchoscopy-guided bronchial epithelium sampling as a tool for selecting the optimal biologic treatment in a patient with severe asthma: a case report
by: Chin-Wei Kuo, et al.
Published: (2019-11-01)